Cochrane2021Ia
Cochrane Review: Roselle for hypertension in adults
Zusammenfassung
Roselle zur Behandlung von Bluthochdruck bei Erwachsenen - Pattanittum, P - 2021 \| Cochrane Library
[Skip to Content](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007894.pub3/full/de#main-content)
[Close cookies message](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007894.pub3/full/de#)
Cookies
Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if y
Kerninformationen
reviews](https://www.cochranelibrary.com/en/about/about-cochrane-reviews) Review - Intervention
- [New search](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007894.pub3/information/de#history)
Collapse all Expand all
## Abstract
available in
### Background
Hypertension is consi...
ension.
### Search methods
For this update, the Cochrane Hypertension Information Specialist searched the following databases and trials registers for randomised controlled trials (RCTs): the Cochrane Hypertension Specialised Register (to 6 August 2021), Cochrane Central Register of Controlled Tri...
handsearched local and regional Chinese databases: CBM, CMCC, TCMLARS, CNKI, CMAC, and the Index to Chinese Periodical Literature (to 14 September 2020), as well as Thai databases (ThaiJO, CUIR, TDC, CMU e‐Theses, TCTR) (to 3 October 2020). There were no language or publication date restrictions.
#...
Fragen zu diesem Thema?
ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.
Jetzt auf ClariMed suchenVerwandte Leitlinien
Cochrane2020
Cochrane Review: First-line combination therapy versus first-line monotherapy for primary hypertension
Cochrane2025
Cochrane Review: Pharmacotherapy for mild hypertension
Cochrane2025
Cochrane Review: Renin inhibitors versus angiotensin receptor blockers for primary hypertension
Cochrane2020
Cochrane Review: Renin inhibitors versus angiotensin converting enzyme (ACE) inhibitors for primary hypertension
Cochrane2025